Pharmacy- Page 44

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Novo Nordisk’s diabetes med Victoza chops cardiovascular risks by 13%

The FINANCIAL -- Novo Nordisk on June 14 announced that Victoza (liraglutide) significantly reduced the risk of the composite primary endpoint of cardiovascular (CV) death, non-fatal myocardial infarction (heart attack) or non-fatal stroke by 13% vs placebo (95% confidence interval [CI]: 0.78;

by The FINANCIAL

June 15, 2016

1 min read

Pharmacy

German Supreme Court Grants Lilly Appeal in Alimta Vitamin Regimen Patent Lawsuit

The FINANCIAL -- The German Federal Supreme Court has granted the appeal by Eli Lilly and Company in the case of Eli Lilly and Company v. Actavis, vacating the prior decision denying infringement.

by The FINANCIAL

June 15, 2016

1 min read

Pharmacy

Merck’s insulin glargine biosimilar candidate matches Lantus in two late-stage studies

The FINANCIAL -- Merck on June 13 announced results from two Phase 3 studies evaluating MK-1293, Merck’s investigational, follow-on biologic insulin glargine candidate for the treatment of people with type 1 and type 2 diabetes.

by The FINANCIAL

June 14, 2016

3 mins read

Pharmacy

Abbott Reports Positive Results From Study Of FreeStyle Libre System

The FINANCIAL -- Abbott on June 13 announced the results of the IMPACT clinical trial, which demonstrated that the FreeStyle Libre system met its primary endpoint of a reduction in time spent in hypoglycemia (low glucose levels, defined as <70 mg/dL1) for

by The FINANCIAL

June 13, 2016

3 mins read

Pharmacy

SANOFI Sanofi Announces Positive Phase 3 Results for Investigational Titratable Fixed-Ratio Combination of Insulin Glargine and Lixisenatide

The FINANCIAL -- Sanofi announced on June 12 the presentation of the results of the pivotal Phase 3 LixiLan-O and LixiLan-L clinical trials with the investigational titratable fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist lixisenatide in adults

by The FINANCIAL

June 13, 2016

5 mins read

Pharmacy

BLINCYTO Improved Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia

The FINANCIAL -- Amgen on June 10 announced new data from a prespecified interim analysis of the Phase 3 TOWER study, in which BLINCYTO (blinatumomab) demonstrated an almost two-fold increase in median overall survival (OS) compared to standard of care (SOC).

by The FINANCIAL

June 10, 2016

1 min read

Pharmacy

Novartis: Blood Disease Drugs Jakavi, Revolade Show Positive Study Results

The FINANCIAL -- Novartis on June 10 announced Phase III data from RESPONSE-2 showing that Jakavi (ruxolitinib) helped patients with polycythemia vera (PV), who did not have an enlarged spleen and were resistant to or intolerant of hydroxyurea, achieve superior hematocrit control

by The FINANCIAL

June 10, 2016

2 mins read

Pharmacy

AstraZeneca enters commercialisation agreement with Aspen for anaesthetic medicines portfolio

The FINANCIAL -- AstraZeneca on June 9 announced it has entered into a commercialisation agreement with Aspen Global Incorporated (AGI), part of the Aspen Group, for rights to its global anaesthetics portfolio outside the US.

by The FINANCIAL

June 9, 2016

1 min read

Pharmacy

Pfizer : FDA Panel Recommends ALO-02 Extended-Release Capsules For Approval

The FINANCIAL -- Pfizer Inc. announced on June 8 that the U.S. Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee voted (9 to 6) in favor of approval of ALO-02

by The FINANCIAL

June 9, 2016

1 min read

Pharmacy

Ultragenyx and Takeda enter into a Collaboration

The FINANCIAL -- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare genetic diseases, and Takeda Pharmaceutical Company Limited (TSE: 4502), on June 8 announced a strategic partnership to develop and commercialize therapies to

by The FINANCIAL

June 8, 2016

1 min read

Previous 1 … 42 43 44 45 46 … 195 Next

Pharmacy- Page 44

Roche ranked the most sustainable healthcare company in the DJSI

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

Novo Nordisk’s diabetes med Victoza chops cardiovascular risks by 13%

German Supreme Court Grants Lilly Appeal in Alimta Vitamin Regimen Patent Lawsuit

Merck’s insulin glargine biosimilar candidate matches Lantus in two late-stage studies

Abbott Reports Positive Results From Study Of FreeStyle Libre System

SANOFI Sanofi Announces Positive Phase 3 Results for Investigational Titratable Fixed-Ratio Combination of Insulin Glargine and Lixisenatide

BLINCYTO Improved Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia

Novartis: Blood Disease Drugs Jakavi, Revolade Show Positive Study Results

AstraZeneca enters commercialisation agreement with Aspen for anaesthetic medicines portfolio

Pfizer : FDA Panel Recommends ALO-02 Extended-Release Capsules For Approval

Ultragenyx and Takeda enter into a Collaboration

Popular Posts

Natali Safaryan – The Voice of Armenia on the International Stage

We Are Proud of Every Jury Member”: Mykyta Harmel and the Global Mission of Golden Time Talent

By 41% to 30% public say government right to u-turn on welfare

Sean Combs Trial: A High-Profile Case Ends in Mixed Verdict, Exposing Prosecutorial Missteps

International Festival of Arts and Talents in London: World Talent Award 2025

Modern bathroom that you will be proud of having it

Artificial intelligence powers record-breaking all-in-one miniature spectrometers

Poverty rate in India was slashed, says report, but globally 1.2bn still poor

Food industry shows ‘stalled progress’ to reduce salt intakes

Depressed people are just more realistic, right? Not so, says UC Berkeley study

Recent Posts

Get updates

Join

Latest comments

Suggestions

Pharmacy- Page 44

Popular Posts

Recent Posts

Get updates

Join

Latest comments